The Cardioprotective Role of Carvedilol, A Non-Selective -Adrenoceptor Blocker, in Albino Rats with Type 2 Diabetes Mellitus

CARVEDILOL AND NEBIVOLOL PROTECT THE KIDNEY AGAINST RENAL ISCHEMIA IN WISTAR RATS.

Molecular signaling pathways in an experimental model of Cardiorenal Syndrome

Aliskiren and L-carnitine attenuate isoproterenol-induced cardiac hypertrophy via targeting IL-6/JAK2/STAT3/SOCS3 signaling pathway

Carvedilol and rosuvastatin mitigate nephrotoxicity of sodium valproate through activation of Nrf2 pathway in rats.

METFORMIN AND CARVEDILOL AMELIORATE ISOPRENALINE-INDUCED MYOCARDIAL INFARCTION IN NON-DIABETIC RATS THROUGH AMPK ACTIVATION AND SUPPRESSION OF APOPTOSIS

Cardiac and Renal Protective Role of Erythropoietin in a Rat Model of Acute Myocardial Infarction

Pharmacogenomics and Heart Failure Patients on Carvedilol

Protective Effect of Angiotensin II Type 1-Receptor-Blocker on Diabetic Nephropathy in Rats: Role of Nephrin

The Role of Fasudil and Ang (1-7) in PAN Induced Nephropathy in rats